Literature DB >> 26669970

Escherichia coli induces platelet aggregation in an FcγRIIa-dependent manner.

R D Moriarty1, A Cox1, M McCall1, S G J Smith2, D Cox1.   

Abstract

BACKGROUND: The discovery of pathogen-recognition receptors such as Toll-like receptors on platelets has led to the emergence of the concept of platelets as important components of the host response to infection. Escherichia coli (E. coli)-mediated sepsis is a serious illness characterized by the occurrence of thrombocytopenia. Whereas there has been a wealth of research on platelet activation by Gram-positive bacteria, little is known about the mechanisms associated with Gram-negative bacteria-induced platelet activation with Gram-negative bacteria.
OBJECTIVES: To determine the mechanisms by which Gram-negative E. coli induces platelet aggregation.
METHODS: Induction of platelet aggregation with E. coli strain O157:H7 was tested in platelet-rich plasma (PRP), washed platelets, and serum depleted of complement factors. Platelet inhibitors (against αII b β3 , glycoprotein Ibα and FcγRIIa) were used. Platelet thromboxane synthesis was analyzed after E. coli stimulation. Cell binding assays were used to assess the ability of E. coli to support platelet adhesion. Trypsinization was used to determine the role of E. coli surface proteins. RESULTS AND
CONCLUSION: E. coli-induced aggregation in PRP was donor-dependent. E. coli O157:H7 induced aggregation with a lag time of 6.9 ± 1.3 min in an αII b β3 -dependent and FcγRIIa-dependent manner. Furthermore, this interaction was enhanced by the presence of complement, and was dependent on thromboxane synthesis. These results show E. coli to be a potent inducer of platelet aggregation.
© 2015 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  Escherichia coli; FcγRIIa; blood platelets; complement system proteins; sepsis

Mesh:

Substances:

Year:  2016        PMID: 26669970     DOI: 10.1111/jth.13226

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  15 in total

1.  Platelet and neutrophil responses to Porphyromonas gingivalis in human whole blood.

Authors:  William A Chen; Hansel M Fletcher; Kimberly J Payne; Sheryl Aka; Melanie B Thornburg; Joseph D Gheorghe; Shahnaj Binte Safi; David Shavlik; Udochukwu Oyoyo; Danilo S Boskovic
Journal:  Mol Oral Microbiol       Date:  2021-04-20       Impact factor: 4.107

2.  Human platelet interaction with E. coli O111 promotes tissue-factor-dependent procoagulant activity, involving Toll like receptor 4.

Authors:  Valeria Matus; J Guillermo Valenzuela; Patricia Hidalgo; L María Pozo; Olga Panes; Aniela Wozniak; Diego Mezzano; Jaime Pereira; Claudia G Sáez
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

Review 3.  The Non-Hemostatic Aspects of Transfused Platelets.

Authors:  Caroline Sut; Sofiane Tariket; Cécile Aubron; Chaker Aloui; Hind Hamzeh-Cognasse; Philippe Berthelot; Sandrine Laradi; Andreas Greinacher; Olivier Garraud; Fabrice Cognasse
Journal:  Front Med (Lausanne)       Date:  2018-02-27

Review 4.  Early Host Interactions That Drive the Dysregulated Response in Sepsis.

Authors:  Steven W Kerrigan; Tatyana Devine; Glenn Fitzpatrick; Jecko Thachil; Dermot Cox
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

5.  Yersinia pestis escapes entrapment in thrombi by targeting platelet function.

Authors:  Samantha G Palace; Olga Vitseva; Megan K Proulx; Jane E Freedman; Jon D Goguen; Milka Koupenova
Journal:  J Thromb Haemost       Date:  2020-09-20       Impact factor: 5.824

Review 6.  Role of Platelets in Detection and Regulation of Infection.

Authors:  Irina Portier; Robert A Campbell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-29       Impact factor: 8.311

Review 7.  Targeting SARS-CoV-2-Platelet Interactions in COVID-19 and Vaccine-Related Thrombosis.

Authors:  Dermot Cox
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

8.  Thrombocytopenia in bacteraemia and association with bacterial species.

Authors:  D Johansson; M Rasmussen; M Inghammar
Journal:  Epidemiol Infect       Date:  2018-05-15       Impact factor: 4.434

9.  Impact of Escherichia coli K12 and O18:K1 on human platelets: Differential effects on platelet activation, RNAs and proteins.

Authors:  A V Fejes; M G Best; W A van der Heijden; A Vancura; H Verschueren; Q de Mast; T Wurdinger; C Mannhalter
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

10.  Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis.

Authors:  Fanny Vardon Bounes; Vincent Mémier; Marina Marcaud; Aemilia Jacquemin; Hind Hamzeh-Cognasse; Cédric Garcia; Jennifer Series; Pierre Sié; Vincent Minville; Marie-Pierre Gratacap; Bernard Payrastre
Journal:  Sci Rep       Date:  2018-09-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.